Carsgen Therapeutics Collaborates with Moderna

CARsgen Therapeutics has announced a collaboration agreement with Moderna to jointly investigate the potential of combining CARsgen's investigational Claudin18.2 CAR T-cell product candidate, known as CT041, with Moderna's investigational Claudin18.2 mRNA cancer vaccine. 

The aim of this collaboration is to conduct preclinical studies and a phase I clinical trial that will assess the effectiveness of the combination therapy.

The focus of this partnership is to explore the synergistic effects of combining CAR-T cell therapy with an mRNA cancer vaccine designed to encode the Claudin18.2 protein. Claudin18.2 is a promising target for therapeutic intervention, especially in cases of various cancer types where there is a significant unmet medical need.

CT041, also referred to as satricabtagene autoleucel, is CARsgen's proprietary CAR T-cell product that is derived from the patient's own cells. It is being investigated as a potential treatment for gastrointestinal cancers, including gastric and pancreatic cancers. 

The therapy has shown promising results in ongoing clinical studies conducted in both China and North America, further bolstering its potential to effectively address these challenging cancer types.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!